Comparative evaluation of the Air Q and Baska Mask in patients undergoing ambulatory surgery under general anesthesia.

This double-blinded, randomized controlled trial aims to compare the efficacy and safety of two supraglottic airway devices—the Baska Mask and the Air-Q—in adult patients undergoing elective minor or ambulatory surgeries under general anesthesia. A total of 118 patients, aged 18–60 years, classified as ASA physical status I or II with a BMI <40 kg/m², will be recruited and randomly assigned to either device group.

Both devices will be inserted by experienced anesthesiologists without the use of neuromuscular blockers, and the primary parameters assessed will include insertion time, ease of insertion, oropharyngeal leak pressure (OLP), ventilation adequacy, and number of insertion attempts. Hemodynamic stability and airway-related complications, including sore throat, mucosal trauma, and postoperative nausea and vomiting, will also be monitored.

The Air-Q, with its self-pressurizing cuff and gastric protection features, is evaluated as a newer alternative to the Baska Mask, which is known for its self-sealing cuff and integrated suction system. The study’s outcomes aim to provide evidence-based guidance on optimal supraglottic airway device selection in daycare surgical settings, where rapid recovery and minimal complications are critical.